Location: Home
  • search
  • go
  • Relate News
  • 6/15/2018Tsumura and PingAn Forms Chinese JV for Herbal Medicine
  • 6/15/2018BMS Wins Chinese Approval of Opdivo as First PD-1/L1 Checkpoint in Chi...
  • 6/15/2018Aptose Licenses China Rights of Crystal Genomics's AML Drug CG-806
  • 6/15/2018China's Investors Pour Into Western Biotech Startups
  • 6/15/2018China's Vaccine Tourists Drain Hong Kong's Supply of Cancer Drug
  • 6/14/2018U.S. Supreme Court Rules against Chinese Companies in Vitamin Price-fi...
  • 6/14/2018Sirtex Dumps Deal with Varian for Higher $1.4B Offer from CDH/China Gr...
  • 6/14/2018Pharnext's Orphan Drug PXT3003 Granted Priority Review in China
  • 6/13/2018NHC Reports Rising Chinese Life Expectancy and Falling Infant Mortalit...
  • 6/13/2018Wuxi AppTech Leads Strategic Investment into AI Firm Insilico Medicine
  • 6/13/2018CStone Initiates Two Pivotal Phase II Studies of Anti-PD-L1 mAb CS1001
  • 6/13/2018BMJ: Protecting the Accuracy of Clinical Trial Data in China
  • 6/13/2018Ascletis Receives Chinese Approval for Its Class 1 HCV Drug Danoprevir
  • 6/13/2018China to Conduct Training Programs for Indian Pharma Cos
  • 6/12/2018Chinese Government Launch Support Program for Biopharma CRO and CMO Se...
  • 6/12/2018CDE Solicits Feedbacks on Two Draft Technical Guidelines for Bioequiva...
  • 6/12/2018Hays: China's Middle Classes Are Growing in Numbers, Wealth and Influe...
  • 6/12/2018China Approves 4-Strain Flu Vaccine for 2018
  • 6/12/2018Suven Life Sciences Wins Patents in China and USA
  • 6/11/2018WuXi Biologics to Build a $60M Biologics Facility in the U.S.
  • 6/10/2018Will China's Promise to Boost Imports Benefit MNC Pharma Companies?
  • 6/8/2018Oncologie Commences Operations in Boston and Shanghai
  • 6/8/2018NMPA Issues 2017 Drug Inspection Report
  • 6/8/2018Recent Executive Moves
  • 6/8/2018Novo Nordisk Still Has Ample Room for Growth in China
  • 6/7/2018CNDA Suspends Import of Ambroxol Hydrochloride from India's Shilpa Med...
  • 6/7/2018CNDA Solicits Comments on 2nd Draft of the GMP Appendices for Narcotic...
  • 6/6/2018Hua Medicine Becomes Second Firm to Seek Hong Kong IPO under New Rules
  • 6/6/2018Guangdong Drug Regulator Sentenced Eight Years for Corruption
  • 6/6/2018CNDA Issues New Announcement (2018#30) for Clinical Data Self-Inspecti...
  • Page:320/774 Total number of articles:23207: [First][<<] [318] [319] [320] [321] [322] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group